The global Aortic Valve Replacement Market size is expected to reach USD 13.49 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 11.1% during the forecast period. Technological advancements in aortic valves and favorable reimbursement policies are boosting the growth of the market. Rising demand for minimally invasive surgeries is also triggering the growth of the market.
Widening base of geriatric population is
one of the key growth stimulants. As per data published by Medicare and
Medicaid services, the number of aortic stenosis patients over 65 years of age
is constantly increasing in the U.S. Thus, rising incidence of aortic stenosis
coupled with improving treatment rates is expected to bolster the growth of the
market over the forecast period. In addition, growing preference for minimally
invasive surgeries is escalating the growth of the market. These procedures
cause lesser trauma to patient along with better outcomes and facilitate faster
recovery than conventional open-heart surgeries. MIS requires relatively lesser
number of hospital stays and is hence economically more viable than
conventional invasive surgeries.
Favorable reimbursement policies are one of
the crucial factors anticipated to drive the market in the near future. Centers
for Medicare & Medicaid Services (CMS) announced that it would provide
coverage for TAVR under the Medicare National Coverage Determination policy.
Moreover, increasing number of clinical studies undertaken by key players for
extending interventional scope, analyzing safety of devices, and assessing
subsequent treatment alternatives is also working in favor of the market.
However, product recalls due to safety concerns are projected to inhibit the
growth of the market.
Request a free sample copy or view report summary: Aortic Valve
Replacement Devices Market Report
Aortic Valve Replacement Devices Market
Report Highlights
- Minimally invasive surgeries emerged as the leading surgery type
owing to various advantages associated with them, such as limited trauma,
quicker recovery, and cost-effectiveness
- The transcatheter valve segment accounted for the largest revenue
share in 2017 due to rising number of clinical studies for expanding their
applications
- In terms of end users, hospitals were the dominant revenue
contributor in 2017 and ambulatory surgery centers (ASCs) are expected to
exhibit remarkable CAGR over the forecast period
- North America emerged as the largest regional market with a revenue
share of 41.9% in 2017 and Asia Pacific is anticipated to post the highest
CAGR over the forecast period
- The market is highly fragmented in nature. Some of the prominent
companies operating in the market are Edwards Lifesciences Corporation,
Boston Scientific Corporation, St. Jude Medical, CryoLife, Medtronic, and
LivoNova.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment